Search

You searched for "presentation"

1963 results found

AOP welcomes report calling for redirection of future funding from secondary to primary and community services

29 February 2024 | AOP, funding, community services, eyecare, optometry, optician, optometrist
The King’s Fund says a shift in focus away from hospital care in England’s ‘failing health and care system’ is essential.

Orbis and Heidelberg Engineering team up on free e-learning opportunities

12 April 2024 | Orbis, charity, international, collaboration, partnership, educational, learning, work
Sight-saving charity Orbis and high-tech imaging and data solutions company Heidelberg Engineering are leveraging technology to provide free clinical education for eye care professionals around the world.

Open Sight Hampshire announces new Chair of Trustees

16 May 2024 | industry, appointments, open sight, charity
Open Sight Hampshire is delighted to announce Jane Brooks as its new Chair of Trustees.

FMLM Conference 2024

26 March 2024
by Somain Verma, Ophthalmology Registrar (ST2), Northampton General Hospital. Clinical leadership is more important than ever. With an ever-increasingly burdened health system, we must assure that appropriate resources and systems are in place to maintain an effective and efficient health...

Long-term use of botulinum toxin for hemifacial spasm and blepharospasm

1 February 2022 | | Neuro-Ophthalmology | Botulinum neurotoxin, benign essential blepharospasm, hemifacial spasm, tolerance
The authors conducted a retrospective review of clinical / procedure documentation for consecutive blepharospasm (BEB) and hemifacial spasm (HFS) patients undergoing treatment with onabotulinum toxin A (Botox) in one clinic setting over the past 20 years. They report on the...
Jaapos journal cover image.

Retrospective safety assessment of apraclonidine for diagnosis of Horner’s syndrome in children

2 August 2022 | | Paediatric Ophthalmology / Strabismus
Apraclonidine has been shown to reverse the anisocoria in Horner’s syndrome, with some reports of partial ptosis resolution. Side-effects of apraclonidine have been reported especially in children under six months old. The authors present a retrospective safety study of using...

CALL TO ACTION: Help the Ridley Eye Foundation ‘reach more of the unreachable’ in the Himalayas

4 October 2023 |
On the 29 November 1949, Harold Ridley carried out the first implant of an intraocular lens (IoL). This was the first major breakthrough in the cure of cataract blindness since Jacques Daviel conducted the first extra-capsular extraction 198 years earlier....

Ophtherminator 3 - Rise of the Machines

3 June 2021 | | Ophthalmology, Retina / Uvea / Vitreous, Imaging
“Bring back life form, priority one, all other priorities are rescinded.” Film buffs will spot this as a chilling quote spoken by Ash (Ian Holm) from the classic sci-fi horror movie Alien (1979). Ash (spoiler alert) is a Hyperdyne Systems...

Artificial intelligence in eyecare: how do we ensure new technologies truly benefit our patients?

3 April 2023 | | Ophthalmology
From monitoring patients with heart disease to improving the early diagnosis of cancer, artificial intelligence (AI) using deep learning techniques is already employed in many different healthcare specialties [1]. In the eyecare field, AI technologies have been used to analyse...

RCOphth 2024 Report

28 May 2024 | | EyeConUK, RCOphth2024, Royal College of Ophthalmology, events, meetings, reports, previews, Eye News
A comprehensive tapestry of all our RCOphth Annual Congress content captured between 20–23 May 2024.

My top five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | AMD
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

My Top Five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | AMD
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...